Table 3.
No CIN | CIN | p value | |
---|---|---|---|
Number of CT scans | 153 (72.5 %) | 58 (27.5 %) | |
Age (years) | 64 (13) | 69 (10) | <0.01 |
Male gender | 88 (57.5 %) | 37 (63.8 %) | 0.41 |
Diabetes mellitus | 22 (14.4 %) | 10 (17.2 %) | 0.61 |
Heart failure | 6 (3.9 %) | 5 (8.6 %) | 0.18 |
Sepsis | 41 (26.8 %) | 15 (25.9 %) | 0.89 |
Baseline GFR < 60 mL/min | 52 (34.0 %) | 44 (75.9 %) | <0.01 |
Haemoglobin (mmol/L) | 6.6 (1.1) | 6.2 (0.88) | 0.01 |
APACHE II score | 19.5 (7.9) | 22.8 (8.9) | <0.01 |
APACHE IV score | 74.5 (29.1) | 92.6 (28.9) | <0.01 |
SOFA day 1 | 8.0 (7.0) | 5.0 (4.0) | <0.01 |
SOFA day 4 | 11.0 (6.0) | 4.0 (3.0) | <0.01 |
Fluid balance (mL/24 h) | 2180 (4566) | 3488 (7251) | 0.03 |
Aminoglycoside (single-dose) use | 5 (3.3 %) | 7 (12.1 %) | 0.02 |
Norepinephrine use | 32 (20.9 %) | 22 (37.9 %) | 0.01 |
Prophylactic therapy | 29 (19.0 %) | 19 (32.8 %) | 0.03 |
Dichotomous data are noted as the number of patients with the presence of the concerning variable in that group (percentage of the entire population). Continuous data are noted as the mean (standard deviation) or median (interquartile range)
CIN contrast-induced nephropathy, CT computed tomography, GFR glomerular filtration rate, APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment